Korea: The FLASH Trial has revealed that artificial intelligence-based fully automated quantitative coronary angiography ...

Patients who suffer a GI bleed after PCI are a challenging group. They may have multiple comorbidities and are often medically unstable; treatment must balance the need to prevent ischemic post ...

The following is a summary of “Early and Long-term Outcomes of Patients with Acute Coronary Syndrome Undergoing Percutaneous ...

in predicting outcome after percutaneous coronary intervention (PCI). Methods and results: cTnI was measured immediately before and at 6, 14, and 24 hours after PCI in 316 consecutive patients with ...

indicating that the clinical benefit observed with manual thrombectomy was not owing to a lower incidence of further intervention. Although the TAPAS trial did not assess infarct size or left ...

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) ...

Blood thinners are essential medications for many people who have undergone a procedure called percutaneous coronary ...

Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few ...

Conavi Medical Corp. (TSXV: CNVI) ("Conavi Medical” or the "Company”), a commercial stage medical device company focused on ...

African American patients that receive PCI for LMCA disease have increased risk for postdischarge bleeding compared with White patients.

Inclacumab is a monoclonal antibody commercialized by Pfizer, with a leading Phase III program in Sickle Cell Disease With Vaso-Occlusive Crisis.